High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

<i>Background</i>: The evidence on high-dose ifosfamide (HD-IFO) use in patients with relapsed osteosarcoma is limited. We performed a retrospective study to analyze HD-IFO activity. <i>Methods</i>: Patients with osteosarcoma relapsed after standard treatment [methotrexate, d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani, Lorenzo D’Ambrosio, Alessandro Comandone, Alberto Righi, Alessandra Longhi, Marilena Cesari, Anna Paioli, Rossella Hakim, Michela Pierini, Emanuela Marchesi, Daniel Vanel, Ymera Pignochino, Davide Maria Donati, Piero Picci, Stefano Ferrari
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2020-10-01
Saila:Cells
Gaiak:
osteosarcoma
high-grade bone sarcoma
pediatric bone tumors
ifosfamide
chemotherapy
PARP1
Sarrera elektronikoa:https://www.mdpi.com/2073-4409/9/11/2389
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak